Monitoring of minimal residual disease in NPM1 mutated acute myeloid leukemia (AML) – a single center experience in 27 patients.
Authors | |
---|---|
Year of publication | 2009 |
Type | Article in Periodical |
Magazine / Source | Blood |
MU Faculty or unit | |
Citation | |
Related projects: |